182 related articles for article (PubMed ID: 3488000)
1. Different expansions of T lymphocyte subpopulations in the lung and corticosteroid-induced changes in patients with active pulmonary sarcoidosis.
Rossi GA; Sacco O; Cosulich E; Balbi B; Risso A; Ravazzoni C
Ann N Y Acad Sci; 1986; 465():130-9. PubMed ID: 3488000
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.
Rossi GA; Sacco O; Cosulich E; Damiani G; Corte G; Bargellesi A; Ravazzoni C
Thorax; 1984 Feb; 39(2):143-9. PubMed ID: 6230751
[TBL] [Abstract][Full Text] [Related]
3. Helper T-lymphocytes in pulmonary sarcoidosis. Functional analysis of a lung T-cell subpopulation in patients with active disease.
Rossi GA; Sacco O; Cosulich E; Risso A; Balbi B; Ravazzoni C
Am Rev Respir Dis; 1986 Jun; 133(6):1086-90. PubMed ID: 2940949
[TBL] [Abstract][Full Text] [Related]
4. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis.
Pinkston P; Saltini C; Müller-Quernheim J; Crystal RG
J Immunol; 1987 Aug; 139(3):755-60. PubMed ID: 3496388
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.
Hunninghake GW; Crystal RG
N Engl J Med; 1981 Aug; 305(8):429-34. PubMed ID: 6454846
[TBL] [Abstract][Full Text] [Related]
8. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.
Ceuppens JL; Lacquet LM; Mariën G; Demedts M; van den Eeckhout A; Stevens E
Am Rev Respir Dis; 1984 Apr; 129(4):563-8. PubMed ID: 6231871
[TBL] [Abstract][Full Text] [Related]
9. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.
Pinkston P; Bitterman PB; Crystal RG
N Engl J Med; 1983 Apr; 308(14):793-800. PubMed ID: 6601235
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.
Greening AP; Nunn P; Dobson N; Rudolf M; Rees AD
Thorax; 1985 Apr; 40(4):278-83. PubMed ID: 3875160
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis.
Martinet Y; Pinkston P; Saltini C; Spurzem J; Müller-Quernheim J; Crystal RG
Am Rev Respir Dis; 1988 Nov; 138(5):1242-8. PubMed ID: 3264483
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.
Hunninghake GW; Gadek JE; Young RC; Kawanami O; Ferrans VJ; Crystal RG
N Engl J Med; 1980 Mar; 302(11):594-8. PubMed ID: 6965420
[TBL] [Abstract][Full Text] [Related]
14. Localization of the immune response in sarcoidosis.
Hunninghake GW; Fulmer JD; Young RC; Gadek JE; Crystal RG
Am Rev Respir Dis; 1979 Jul; 120(1):49-57. PubMed ID: 313729
[TBL] [Abstract][Full Text] [Related]
15. [Bronchoalveolar lavage in patients with sarcoidosis--methodologic aspects of the collection, immunologic characterization of lymphocytes and studies of immunoglobulin content].
Ballin A; Bigl H; Ferner S; Fiebig H; Leonhardt P; Neubert R; Cebulla M
Z Erkr Atmungsorgane; 1988; 170(2):108-17. PubMed ID: 2969649
[TBL] [Abstract][Full Text] [Related]
16. Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis.
Hunninghake GW
Ann N Y Acad Sci; 1986; 465():82-90. PubMed ID: 2425678
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis.
Hunninghake GW; Bedell GN; Zavala DC; Monick M; Brady M
Am Rev Respir Dis; 1983 Oct; 128(4):634-8. PubMed ID: 6226225
[TBL] [Abstract][Full Text] [Related]
18. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
Petrek M; Kolek V
Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
[TBL] [Abstract][Full Text] [Related]
19. Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis.
Forrester JM; Newman LS; Wang Y; King TE; Kotzin BL
J Clin Invest; 1993 Jan; 91(1):292-300. PubMed ID: 8423227
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
Hunninghake GW; Crystal RG
J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]